Home›Companies›Biotech & Pharma›OverT Bio

OverT Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing May 9, 2024·Suggest an edit

About OverT Bio

OverT Bio is a private company based in New York, New York, incorporated in 2022 in Delaware. It has reported $15,989,924 raised in one offering on Form D since May 2023. Its chief executive is Mateusz Legut.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 4, 2023May 3, 2023amended May 9, 2024$15,989,924of $17.0M target15$1.0MEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on OverT Bio's Form D filed May 9, 2024.

ML
Mateusz Legut
Chief Executive Officer and director
VB
SC
Sara Choi
Director
NS

Sources

  1. SECOverT Bio, Inc. Form D, filed May 3, 2023
  2. SECOverT Bio, Inc. filing history